Coated-tube radioimmunoassay for C-telopeptides of type I collagen to assess bone resorption

Clinical Chemistry

Volumn 42, Issue 10, 1996, Pages 1639-1644

  Bonde, Martin ^a   Fledelius, Christian ^a   Qvist, Per ^a   Christiansen, Claus ^b  

^a NORDIC BIOSCIENCE A S   (Denmark)

^b CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

Author keywords

biotin steptavidin interaction; menopausal status; peptic fragments; urine

Indexed keywords

COLLAGEN TYPE 1; PEPTIDE DERIVATIVE;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; MENOPAUSE; NORMAL HUMAN; OSTEOLYSIS; PEPTIDE ANALYSIS; POSTMENOPAUSE; PREMENOPAUSE; RADIOIMMUNOASSAY; URINALYSIS;

EID: 0029905159     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.10.1639     Document Type: Article

References (17)

1. Delmas PD. Biochemical markers of bone turnover. J Bone Miner Res 1993;8(Suppl 2):549-55.
2. Eyre DR, Koob TJ, Van Ness KP. Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal Biochem 1984;137:380-8.
3. Fujimoto D, Suzuki M, Uchiyama A, Miyamoto S, Inoue T. Analysis of pyridinoline, a cross-linking compound of collagen fibres, in human urine. J Biochem 1983;94:1133-6.
4. Seyedin EM, Kung VT, Daniloff YN, Hesley RP, Gomez B, Nielsen LA, et al. Immunoassay for urinary pyridinoline: the new marker for bone resorption. J Bone Miner Res 1993;8:635-41.
5. Fledelius C, Riis BJ, Overgaard K, Christiansen C. The diagnostic validity of urinary free pyridinolines to identify women at risk of osteoporosis. Calcif Tissue Int 1994;54:381-4.
6. Garnero P, Gineyts E, Arbaudt P, Christiansen C, Delmas PD. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J Bone Miner Res 1995;10:641-9.
7. Hanson DA, Weis MAE, Bollen A-M, Maslan SL, Singer FR, Eyre DR. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 1992;7:1251-8.
8. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C. Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem 1994;40:2022-5.
9. Garnero P, Gineyts E, Riou JP, Delmas PD. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. J Clin Endocrinol Metab 1994;79: 780-5.
10. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C. Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): follow-up on hormone replacement therapy and osteoporosis risk assessment. J Clin Endocrinol Metab 1995;80:864-8.
11. Soinila S, Mpitsos GJ, Soinila J. Immunohistochemistry of enkephalins: model studies on hapten-carrier conjugates and fixation methods. J Histochem Cytochem 1992;2:231-9.
12. Kearney JF, Radbuch A, Liesegang B, Rajewsky KA. A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol 1979;123:1548-50.
13. Bonde M, Frøkier H, Pepper Duncan S. Selection of monoclonal antibodies for immunoaffinity chromatography: model studies with antibodies against soybean trypsin inhibitor. J Biochem Biophys Methods 1991;23:73-82.
14. Pedersen BJ, Bonde M. Purification of human procollagen type I carboxyl-terminal propeptide cleared as in vivo from procollagen and used to calibrate a radioimmunoassay of the propeptide. Clin Chem 1994;40:811-6.
15. Fledelius C, Kolding I, Bonde M, Cloos P, Christgau S. Specificity of the CrossLaps™ ELISA and the MabA7 ELISA. Osteoporosis Int 1996;6(Suppl 1):PM0440.
16. Christiansen C. Prophylactic treatment for age-related bone loss in women. In: Christiansen C, Arnaud CD, Nordin BEC, et al., eds. Osteoporosis. Proceedings of Copenhagen International Symposium on Osteoporosis. Copenhagen: Osteopress ApS, 1984: 587-93.
17. Reid J, Ames R, Evans M, Gamble G, Sharpe S. Effect of calcium supplementum in postmenopausal women. N Engl J Med 1993; 328:460-4.